UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`MYLAN PHARMACEUTICALS INC. and MYLAN LABORATORIES
`LIMITED,
`Petitioners,
`
`v.
`
`UCB PHARMA GMBH,
`Patent Owner.
`
`Case IPR2016-005101
`Patent 6,858,650 B1
`
`
`
`
`PATENT OWNER’S REQUEST FOR ORAL ARGUMENT
`UNDER 37 C.F.R. § 42.70(a)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1 Petitioners Alembic Pharmaceuticals Limited from IPR2016-01596, Torrent
`Pharmaceuticals Limited from IPR2016-01636, and Amerigen Pharmaceuticals
`Limited from IPR2016-01665 have been joined as Petitioners to this proceeding.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`MYLAN PHARMACEUTICALS INC. and MYLAN LABORATORIES
`LIMITED,
`Petitioners,
`
`v.
`
`UCB PHARMA GMBH,
`Patent Owner.
`
`Case IPR2016-005101
`Patent 6,858,650 B1
`
`
`
`
`PATENT OWNER’S REQUEST FOR ORAL ARGUMENT
`UNDER 37 C.F.R. § 42.70(a)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`1 Petitioners Alembic Pharmaceuticals Limited from IPR2016-01596, Torrent
`Pharmaceuticals Limited from IPR2016-01636, and Amerigen Pharmaceuticals
`Limited from IPR2016-01665 have been joined as Petitioners to this proceeding.
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2016-00510
`Patent 6,858,650 B1
`
`
`
`Pursuant to 37 C.F.R. § 42.70(a), Patent Owner UCB Pharma GmbH
`
`(“UCB” or “Patent Owner”) requests oral argument in IPR2016-00510, IPR2016-
`
`00512, IPR2016-00514, IPR2016-00516, and IPR2016-00517. Pursuant to the
`
`Board’s July 26, 2016 Consolidated Scheduling Order,2 UCB understands that oral
`
`argument is currently scheduled for April 5, 2017.
`
`Pursuant to 37 C.F.R. § 42.70(a), UCB respectfully requests up to sixty (60)
`
`minutes of oral argument per side on all issues raised in the Corrected Petition
`
`(Paper 5), the Patent Owner Preliminary Response (Paper 9), the Board’s
`
`Institution Decision (Paper 12), the Patent Owner Response (Paper 20), and the
`
`Petitioner’s Corrected Reply (Paper 28). These issues include, but are not limited
`
`to, the following:
`
`1. The scope and content of the prior art.
`
`2. The patentability of claims 1-5 and 21-24 of U.S. Patent No. 6,858,650,
`
`claims 1-16 of U.S. Patent No. 7,384,980, claims 1-5 of U.S. Patent No.
`
`7,855,230, claims 1-3, 5-8, and 10-12 of U.S. Patent No. 8,338,478, and
`
`claims 1, 3, 4, and 6-8 of U.S. Patent No. 7,985,772 over the combination
`
`of Postlind (Ex. 1010), Bundgaard publications (Exs. 1012 and 1020),
`
`Detrol® Label (Ex. 1009), and Berge (Ex. 1013) under 35 U.S.C. § 103.
`
`2 The schedule in this case was consolidated with the schedules of related cases
`IPR2016-00512, IPR2016-00514, IPR2016-00516, and IPR2016-00517. See
`IPR2016-00516, Paper 13.
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2016-00510
`Patent 6,858,650 B1
`
`
`
`3. The patentability of claims 1-5 and 21-24 of U.S. Patent No. 6,858,650
`
`over the combination of Brynne (Ex. 1011), Bundgaard publications
`
`(Exs. 1012 and 1020), and Johansson (Ex. 1005) under 35 U.S.C. § 103.
`
`4. The patentability of claims 1-16 of U.S. Patent No. 7,384,980, claims 1-5
`
`of U.S. Patent No. 7,855,230, claims 1-3, 5-8, and 10-12 of U.S. Patent
`
`No. 8,338,478, and claims 1, 3, 4, and 6-8 of U.S. Patent No. 7,985,772
`
`over the combination of Brynne (Ex. 1011), Bundgaard (Ex. 1012), and
`
`Johansson (Ex. 1005) under 35 U.S.C. § 103.
`
`5. Any future issues raised by the Petitioner in its filings or at the oral
`
`argument.
`
`6. Any additional issues on which the Board seeks information or
`
`clarification.
`
`Subject to the Board’s approval, UCB intends to use demonstrative exhibits
`
`during the oral argument. Such demonstrative exhibits will be served in due
`
`course according to 37 C.F.R. § 42.70(b). UCB also intends to request the use of
`
`audio-visual equipment during its presentation, including a computer, projector,
`
`and screen on which to display demonstrative exhibits.
`
`
`
`
`2
`
`
`
`
`
`
`
`IPR2016-00510
`Patent 6,858,650 B1
`
`
`
`
`
`Date: March 8, 2017
`
`
`
`
`
`
`Respectfully submitted,
`
`WHITE & CASE LLP
`/Jeffrey J. Oelke/ (Electronically signed)
`Jeffrey J. Oelke, Reg. No. 37,409
`joelke@whitecase.com
`James S. Trainor, Jr., Reg. No. 52,297
`jtrainor@whitecase.com
`Robert E. Counihan, Reg. No. 61,382
`rcounihan@whitecase.com
`White & Case LLP
`1155 Avenue of the Americas
`New York, NY 10036
`(212) 819-8200
`Attorneys for UCB Pharma GmbH
`
`
`3
`
`
`
`
`
`
`
`IPR2016-00510
`Patent 6,858,650 B1
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent
`
`Owner’s Request for Oral Argument Under 37 C.F.R. § 42.70(a) was served on
`
`March 8, 2017, by filing this document through the Patent Trial and Appeal Board
`
`End to End system as well as delivering a copy via electronic mail upon the
`
`following attorneys of record for the Petitioners:
`
`Mitchell G. Stockwell, Reg. No. 39,389
`mstockwell@kilpatricktownsend.com
`D. Clay Holloway, Reg. No. 58,011
`cholloway@kilpatricktownsend.com
`Alyson L. Wooten, Reg. No. 58,045
`awooten@kilpatricktownsend.com
`Kilpatrick Townsend & Stockton LLP
`1100 Peachtree Street, NE Suite 2800
`Atlanta, Georgia 30309
`(404) 815-6500
`
`
`
`William Hare, Reg. No. 44,739
`bill@miplaw.com
`Gabriela Materassi, Reg. No. 47,774
`materassi@miplaw.com
`Renita S. Rathinam, Reg. No. 53,502
`rathinam@miplaw.com
`MCNEELY, HARE & WAR LLP
`5335 Wisconsin Ave., NW
`Suite 440
`Washington, DC 20015
`(202) 640-1801
`
`
`4
`
`
`
`
`
`
`
`
`
`
`
`IPR2016-00510
`Patent 6,858,650 B1
`
`
`
`Neal Seth, Reg. No. 67,075
`nseth@wileyrein.com
`Lawrence Sung, Reg. No. 38,330
`lsung@wileyrein.com
`WILEY REIN LLP
`1776 K Street NW
`Washington, DC 20006
`(202) 719-7000
`
`Manish Mehta, Reg. No. 64, 570
`mmehta@sheppardmulllin.com
`Laura Burson, Reg. No. 40,929
`lburson@sheppardmullin.com
`SHEPPARD MULLIN
`Three First National Plaza
`70 West Madison Street, 48th Floor
`Chicago, Illinois 60602
`(312) 499-6300
`
`
`
`
`
`
`
`
`
`
`
`
`/Jeffrey J. Oelke/ (Electronically signed)
`Jeffrey J. Oelke
`Reg. No. 37,409
`Phone: (212) 819-8936
`
`
`Date: March 8, 2017
`
`
`
`
`
`5
`
`
`
`
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
